Skip to main content
. 2018 Sep 30;37(3):230–238. doi: 10.23876/j.krcp.2018.37.3.230

Figure 1. Prevalence of renal impairment among tenofovir diso-proxil fumarate (TDF) and non-TDF groups.

Figure 1

Renal impairment was defined as glomerular filtration rate (GFR) < 90 mL/min/1.73 m2; CKD as GFR < 60 mL/min/1.73 m2 persisting from baseline to the 16th and/or the 24th week. P for association between GFR and TDF use at baseline, the 16th and the 24th week were 0.254, 0.038, and 0.027, respectively.